AstraZeneca Receives FDA Approval for Hypertension Drug Baxfendy
AstraZeneca (AZN) has received U.S. Food and Drug Administration approval for its hypertension drug, Baxfendy (baxdrostat), as a first-in-class aldosterone synthase inhibitor to treat high blood pressure in adults not adequately controlled by other medications.
Tickers: $AZN
Topics: drug approval hypertension treatment pharmaceuticals